Here are all 12 topics answered in the simplest possible language:
Biochemistry LAQs - Paper 1 - Simple Answers
1. VITAMIN D METABOLISM
1. Endogenous Synthesis in Skin
- Sunlight (UV-B) hits the skin and converts a cholesterol-like compound (7-dehydrocholesterol) into Vitamin D3 (cholecalciferol).
- Think of it as: Sun + skin cholesterol = Vitamin D3
2. Sequential Hydroxylations (Making the Active Form)
Vitamin D3 is useless on its own. It must be activated in two steps:
| Step | Where | Enzyme | Product |
|---|
| 1st hydroxylation | Liver | 25-hydroxylase | 25-(OH)D3 (calcidiol) - storage form |
| 2nd hydroxylation | Kidney | 1α-hydroxylase | 1,25-(OH)₂D3 (calcitriol) - ACTIVE form |
- Calcitriol is the fully active hormone.
- Low calcium or PTH stimulates the kidney to make more calcitriol.
3. Role in Calcium Homeostasis
Calcitriol does 3 things to raise blood calcium:
- Gut - increases calcium absorption from food
- Bone - releases calcium from bones (with PTH)
- Kidney - reduces calcium loss in urine
Simple rule: Calcitriol = raises blood calcium
4. Deficiency Disorders
- Children → Rickets: soft, deformed bones; bow legs, knock knees, "rachitic rosary" on ribs
- Adults → Osteomalacia: soft bones, bone pain, muscle weakness
- Elderly/severe → Osteoporosis (combined with other factors)
- Cause of deficiency: lack of sunlight, poor diet, kidney disease (can't make calcitriol), liver disease
2. FATTY ACIDS
1. Activation (Turning Fat into a Usable Form)
- Fatty acids must be "activated" before they can be burned.
- They combine with CoA (coenzyme A) to form Fatty acyl-CoA.
- This happens in the cytoplasm (cytosol).
- Enzyme: Acyl-CoA synthetase (also called thiokinase)
- Costs 2 ATP (ATP → AMP, so equivalent to 2 ATP lost)
2. Mitochondrial Transport - The Carnitine Shuttle
- Fatty acyl-CoA is too big to cross the mitochondrial inner membrane on its own.
- Carnitine acts as a "ferry" or "taxi" to carry it across.
Steps:
- Fatty acyl-CoA + Carnitine → Acylcarnitine (enzyme: CPT-1, on outer membrane)
- Acylcarnitine crosses the inner membrane via a transporter
- Inside: Acylcarnitine → Fatty acyl-CoA + Carnitine released (enzyme: CPT-2)
- Carnitine ferries back out
- CPT-1 is the rate-limiting step and is inhibited by malonyl-CoA (so when you're making fat, you don't burn it at the same time - smart!)
3. Reactions of the Spiral (Beta-oxidation) Pathway
Each "round" of beta-oxidation removes 2 carbons as Acetyl-CoA:
| Step | Reaction | Product |
|---|
| 1 | Oxidation | FADH₂ produced |
| 2 | Hydration (water added) | - |
| 3 | Oxidation again | NADH produced |
| 4 | Thiolysis (cut by CoA) | Acetyl-CoA released + shorter fatty acyl-CoA |
This repeats (spirals) until the whole chain is gone.
4. Energy from Palmitic Acid (16 carbons)
- Palmitic acid (C16) goes through 7 rounds of beta-oxidation
- Products: 8 Acetyl-CoA + 7 FADH₂ + 7 NADH
Calculating ATP:
- 8 Acetyl-CoA × 10 ATP = 80 ATP
- 7 FADH₂ × 1.5 ATP = 10.5 ATP
- 7 NADH × 2.5 ATP = 17.5 ATP
- Total = 108 ATP
- Subtract 2 ATP for activation = Net 106 ATP
5. Associated Metabolic Blocks
- Carnitine deficiency: Can't transport fatty acids into mitochondria → fat accumulates, muscle weakness, hypoglycemia
- CPT-1 deficiency: Same result as carnitine deficiency
- MCAD deficiency (medium-chain acyl-CoA dehydrogenase): Can't oxidize medium-chain fats; dangerous in fasting - hypoglycemia, sudden death in children
- Refsum disease: Can't oxidize branched-chain fatty acids → nerve damage
3. VITAMIN B12
1 & 2. Absorption and Transport (Intrinsic Factor)
- B12 from food binds to R-protein (haptocorrin) in saliva first.
- In the stomach, Intrinsic Factor (IF) is made by parietal cells.
- In the small intestine, R-protein is digested off and B12 binds to IF.
- The B12-IF complex is absorbed in the terminal ileum (last part of small intestine) via specific receptors (cubilin).
- In blood, B12 is carried by proteins called transcobalamin I, II, III.
- Transcobalamin II is the most important for delivery to cells.
3. Biochemical Role as a Coenzyme
B12 (cobalamin) acts as a coenzyme in 2 key reactions:
Reaction 1 (uses methylcobalamin):
- Converts homocysteine → methionine
- Enzyme: methionine synthase
- Also regenerates THF (tetrahydrofolate) from methyl-THF
- This is the link between B12 and folate!
Reaction 2 (uses adenosylcobalamin):
- Converts methylmalonyl-CoA → succinyl-CoA
- Enzyme: methylmalonyl-CoA mutase
- Important for odd-chain fatty acid oxidation
- Deficiency → methylmalonic acid builds up in blood/urine (diagnostic marker)
4. Neurological Manifestations
B12 deficiency causes nerve damage because myelin (nerve insulation) breaks down:
- Subacute combined degeneration of spinal cord - affects both sensory and motor tracts
- Symptoms: Tingling/numbness in hands & feet (peripheral neuropathy), balance problems, difficulty walking, dementia, depression, memory loss
- Remember: folate deficiency gives anemia but NOT the neurological damage
5. The Folate Trap
- B12 is needed to convert methyl-THF → THF
- Without B12, all folate gets "trapped" as methyl-THF (a dead-end form)
- THF is needed to make DNA building blocks
- So B12 deficiency → effectively traps folate → can't make DNA → megaloblastic anemia (same as folate deficiency anemia)
- This is why giving folate to a B12-deficient patient fixes the blood but doesn't fix the nerve damage - a dangerous situation!
4. CHOLESTEROL BIOSYNTHESIS
1. Intracellular Pathway from Acetyl-CoA
Simple steps:
- 2 Acetyl-CoA → Acetoacetyl-CoA
- + 1 more Acetyl-CoA → HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) - in cytosol
- HMG-CoA → Mevalonate ← RATE-LIMITING STEP (enzyme: HMG-CoA reductase)
- Mevalonate → Isoprene units (IPP)
- 6 Isoprene units → Squalene (30C)
- Squalene → Lanosterol → Cholesterol (27C)
Site: Mostly in liver, in the endoplasmic reticulum (smooth ER)
2. Rate-Limiting Step: HMG-CoA Reductase
- This enzyme converts HMG-CoA → Mevalonate
- It is the bottleneck of the whole pathway
- Statins (e.g., atorvastatin, lovastatin) BLOCK this enzyme → less cholesterol made
3. Feedback Regulation
- High cholesterol → SREBP (a transcription factor) is kept inactive → less HMG-CoA reductase made
- Low cholesterol → SREBP becomes active → more HMG-CoA reductase made → more cholesterol
- Insulin activates HMG-CoA reductase (fed state = make cholesterol)
- Glucagon and cortisol inhibit it (fasting = save energy)
- Cholesterol also reduces LDL receptor expression (so less uptake from blood when already plenty)
4. Products Derived from Cholesterol
- Bile acids/salts - for fat digestion
- Steroid hormones - cortisol, aldosterone, sex hormones (estrogen, testosterone, progesterone)
- Vitamin D - made from cholesterol in skin
- Cell membranes - cholesterol gives rigidity
- Myelin in nerves
5. GLYCOLYSIS
1. Complete Pathways
Glycolysis = breakdown of glucose (6C) to pyruvate (3C), happening in the cytoplasm
10 steps (simplified):
- Glucose + ATP → Glucose-6-phosphate (enzyme: hexokinase/glucokinase)
- G-6-P → Fructose-6-phosphate
- F-6-P + ATP → Fructose-1,6-bisphosphate (PFK-1 - RATE LIMITING STEP)
- F-1,6-BP → 2× DHAP + G3P
- DHAP → G3P (so now 2× G3P)
- G3P → 1,3-BPG (+ 2 NADH made)
- 1,3-BPG → 3-phosphoglycerate (+ 2 ATP by substrate-level phosphorylation)
- 3-PG → 2-phosphoglycerate
- 2-PG → Phosphoenolpyruvate (PEP)
- PEP → Pyruvate (+ 2 ATP) - enzyme: pyruvate kinase
Aerobic fate of pyruvate (oxygen present):
- Pyruvate → Acetyl-CoA (pyruvate dehydrogenase) → TCA cycle → lots of ATP
Anaerobic fate (no oxygen, e.g., RBCs, exercising muscle):
- Pyruvate → Lactate (lactate dehydrogenase)
- This regenerates NAD+ so glycolysis can keep going
- Net: 2 ATP per glucose (no oxygen)
2. Rate-Limiting Steps
- Hexokinase/Glucokinase (Step 1)
- PFK-1 (Step 3) - THE MOST IMPORTANT rate-limiting step
- Pyruvate kinase (Step 10)
3. Hormonal Regulation
| Hormone | Effect on Glycolysis | Mechanism |
|---|
| Insulin | Activates | Activates PFK-1, pyruvate kinase |
| Glucagon | Inhibits | Inactivates PFK-1 via F-2,6-BP reduction |
| Adrenaline | Inhibits (in liver) | Same as glucagon |
- PFK-1 is activated by: AMP, ADP, F-2,6-BP (low energy signal → make energy)
- PFK-1 is inhibited by: ATP, citrate (high energy signal → no need to make more)
4. Energetics
| Condition | ATP Made | ATP Used | Net ATP |
|---|
| Anaerobic | 4 | 2 | 2 ATP |
| Aerobic | 4 + (NADH → ~32 more via TCA/OxPhos) | 2 | ~32 ATP total |
Glycolysis itself only makes: 2 ATP + 2 NADH + 2 Pyruvate
5. Rapoport-Luebering Shunt
- Normally: 1,3-BPG → 3-PG (makes ATP)
- In the shunt: 1,3-BPG → 2,3-BPG → 3-PG (NO ATP made!)
- Why is it important? 2,3-BPG binds to hemoglobin and reduces its affinity for oxygen → hemoglobin releases O₂ more easily to tissues
- Especially important in RBCs (which cannot make ATP by any other means)
- Clinical: stored blood has low 2,3-BPG → Hb holds O₂ tightly → tissues don't get enough O₂ (transfusion problem)
6. TCA CYCLE (Krebs Cycle / Citric Acid Cycle)
1. Detailed Steps
Starts with Acetyl-CoA (2C) + Oxaloacetate (4C) = Citrate (6C)
| Step | Reaction | Important Product |
|---|
| 1 | Acetyl-CoA + OAA → Citrate | - |
| 2 | Citrate → Isocitrate | - |
| 3 | Isocitrate → α-ketoglutarate | CO₂ + NADH |
| 4 | α-ketoglutarate → Succinyl-CoA | CO₂ + NADH (rate-limiting!) |
| 5 | Succinyl-CoA → Succinate | GTP (= ATP) |
| 6 | Succinate → Fumarate | FADH₂ |
| 7 | Fumarate → Malate | - |
| 8 | Malate → OAA | NADH |
Per one Acetyl-CoA turn: 3 NADH + 1 FADH₂ + 1 GTP + 2 CO₂
2. Regulatory Checkpoints
Regulated at 3 enzymes (all inhibited by high energy):
| Enzyme | Activated by | Inhibited by |
|---|
| Citrate synthase | Low OAA | ATP, NADH, succinyl-CoA |
| Isocitrate dehydrogenase | ADP | ATP, NADH |
| α-ketoglutarate dehydrogenase | Ca²⁺ | ATP, NADH, succinyl-CoA |
3. Energetics (ATP yield per Acetyl-CoA)
- 3 NADH × 2.5 ATP = 7.5 ATP
- 1 FADH₂ × 1.5 ATP = 1.5 ATP
- 1 GTP = 1 ATP
- Total = 10 ATP per Acetyl-CoA
Per glucose (2 Acetyl-CoA): 20 ATP from TCA alone
4. Amphibolic and Anaplerotic Roles
Amphibolic = the cycle serves BOTH breaking down AND building up:
- Breaking down: burns acetyl-CoA for energy (catabolism)
- Building up: provides building blocks for making amino acids, fatty acids, glucose (anabolism)
Anaplerotic = reactions that "fill up" the cycle when intermediates are used up:
- Most important: Pyruvate carboxylase converts pyruvate → OAA (replenishes OAA)
- Also: amino acids feed in (e.g., glutamate → α-ketoglutarate)
- Why needed: if OAA runs low, the cycle slows down even if Acetyl-CoA is available
7. ENZYME INHIBITION
1. Competitive vs Non-Competitive Inhibition
| Feature | Competitive | Non-Competitive |
|---|
| Where inhibitor binds | Active site (competes with substrate) | Allosteric site (elsewhere on enzyme) |
| Can it be overcome? | Yes, by adding more substrate | No |
| Effect on Km | INCREASES (lower affinity) | No change |
| Effect on Vmax | No change | DECREASES |
| Example | Statins (compete with HMG-CoA) | Heavy metal poisoning |
Simple memory:
- Competitive: inhibitor and substrate fight for the same seat. More substrate = inhibitor loses.
- Non-competitive: inhibitor sits somewhere else and slows the enzyme down regardless.
2. Lineweaver-Burk Plots (Double Reciprocal Plot)
This is a graph of 1/V (y-axis) vs 1/[S] (x-axis):
- X-intercept = -1/Km
- Y-intercept = 1/Vmax
Competitive inhibition on the graph:
- Lines cross on Y-axis (same Vmax)
- X-intercept shifts (different Km - higher Km with inhibitor)
Non-competitive inhibition on the graph:
- Lines cross on X-axis (same Km)
- Y-intercept shifts up (lower Vmax)
3. Changes in Km and Vmax
| Inhibitor Type | Km | Vmax |
|---|
| Competitive | Increases | Same |
| Non-competitive | Same | Decreases |
| Mixed | Increases | Decreases |
| Uncompetitive | Decreases | Decreases |
4. Clinical Examples
Statins (e.g., atorvastatin)
- Competitive inhibitor of HMG-CoA reductase
- Blocks cholesterol synthesis
- Used for: high cholesterol, preventing heart attacks
Aspirin
- Irreversible (suicide) inhibitor of COX-1 and COX-2 enzymes
- Blocks prostaglandin and thromboxane synthesis
- Effect: anti-platelet, anti-inflammatory, analgesic
- Irreversible means even adding more arachidonic acid won't help (different from competitive)
8. OXIDATIVE PHOSPHORYLATION
1. The Mitochondrial Respiratory Chain (Complexes I-V)
The inner mitochondrial membrane has 5 protein complexes:
| Complex | Name | Action | Transfers to |
|---|
| I | NADH dehydrogenase | NADH → NAD⁺; pumps 4H⁺ | CoQ (ubiquinone) |
| II | Succinate dehydrogenase | FADH₂ → FAD; NO H⁺ pumped | CoQ |
| III | Cytochrome bc1 | Pumps 4H⁺ | Cytochrome C |
| IV | Cytochrome c oxidase | Pumps 2H⁺; O₂ → H₂O | Terminal step |
| V | ATP synthase | H⁺ flow back → makes ATP | - |
Mobile carriers: CoQ (between I/II and III), Cytochrome C (between III and IV)
2. Chemiosmotic Theory (Mitchell's Theory)
Simple version:
- Complexes I, III, IV pump H⁺ (protons) OUT of the mitochondrial matrix → intermembrane space
- This creates a proton gradient (electrochemical gradient) - like a battery
- H⁺ wants to flow back in - can only do so through Complex V (ATP synthase)
- H⁺ flowing back through Complex V drives ATP synthesis
- This is called chemiosmosis - chemical + osmosis (concentration gradient)
Simple analogy: H⁺ pumped out = water behind a dam; ATP synthase = the turbine; H⁺ flowing back = water turning the turbine to generate electricity (ATP)
3. Inhibitors and Uncouplers
Electron transport inhibitors (block H⁺ pumping):
- Rotenone (insecticide) - blocks Complex I
- Antimycin A - blocks Complex III
- Cyanide (CN⁻), CO, Azide - block Complex IV → death (no ATP made, O₂ not used)
ATP synthase inhibitors:
- Oligomycin - directly blocks Complex V → no ATP made
Uncouplers (make inner membrane leaky to H⁺):
- H⁺ leaks back WITHOUT going through ATP synthase
- Gradient is destroyed → no ATP made
- BUT electrons still flow → energy released as HEAT instead
- Example: 2,4-DNP (dinitrophenol) - once used as a diet pill (dangerous!)
- Example: Thermogenin (UCP-1) in brown fat - natural uncoupler that generates heat in newborns/hibernating animals
9. PROTEIN BIOSYNTHESIS (Translation)
1. Phases of Translation in Prokaryotes
Initiation:
- Small ribosome subunit (30S) binds to mRNA at the Shine-Dalgarno sequence
- Initiator tRNA (fMet-tRNA) comes in - carrying formyl-methionine (fMet)
- Large subunit (50S) joins → complete 70S ribosome
- Needs: IF1, IF2, IF3 (initiation factors) + GTP
Elongation (repeating cycle):
- Aminoacyl-tRNA enters the A site (with EF-Tu + GTP)
- Peptide bond formed between growing chain (P site) and new amino acid (A site)
- Enzyme: peptidyl transferase (part of 23S rRNA - a ribozyme!)
- Ribosome moves one codon forward (translocation) - needs EF-G + GTP
- tRNA moves: A→P→E (Exit site)
Termination:
- A stop codon (UAA, UAG, UGA) enters the A site
- No tRNA fits - instead release factors (RF1, RF2) bind
- Polypeptide chain released
- Ribosome dissociates
2. Initiation and Elongation Factors
| Factor | Role |
|---|
| IF1 | Prevents tRNA from entering A site during initiation |
| IF2 | Brings initiator tRNA to ribosome (needs GTP) |
| IF3 | Prevents premature joining of large subunit; helps select start codon |
| EF-Tu | Delivers aminoacyl-tRNA to A site (needs GTP) |
| EF-Ts | Recycles EF-Tu |
| EF-G | Causes translocation (needs GTP) |
3. Codon-Anticodon Recognition and Wobble Hypothesis
- Each codon (3 bases on mRNA) is read by an anticodon (3 bases on tRNA)
- Positions 1 & 2 of codon must match EXACTLY
- Position 3 (wobble position) can be flexible - one tRNA can read multiple codons!
Wobble rules:
- Inosine (I) in tRNA anticodon can pair with U, C, or A in mRNA
- This means we need FEWER tRNA types than codons (only ~45 tRNA for 61 codons)
4. Post-Translational Modifications
After the protein is made, it's modified:
- Glycosylation - sugars added (in ER/Golgi) → glycoproteins
- Phosphorylation - phosphate group added → activates/deactivates proteins (signaling)
- Methylation, acetylation - common for histone proteins
- Hydroxylation - proline → hydroxyproline in collagen (needs Vitamin C!)
- Signal peptide cleavage - signal sequence cut off after protein reaches destination
- Disulfide bond formation - stabilizes protein structure (in ER)
- Ubiquitination - tags protein for destruction
10. ACID-BASE REGULATION
1. Buffer Mechanisms
Respiratory buffer (fast, within minutes):
- Lungs control CO₂
- Too acidic → breathe faster → blow off CO₂ → pH rises
- Too alkaline → breathe slower → retain CO₂ → pH falls
- CO₂ + H₂O ↔ H₂CO₃ ↔ H⁺ + HCO₃⁻
Renal buffer (slow, takes hours-days):
- Kidneys control HCO₃⁻
- Too acidic → kidneys absorb more HCO₃⁻, excrete more H⁺ (as NH₄⁺ and H₂PO₄⁻)
- Too alkaline → kidneys excrete more HCO₃⁻, retain H⁺
- Bicarbonate buffer is the most important buffer in blood
Other buffers:
- Hemoglobin (in RBCs) - buffers CO₂ in blood
- Phosphate buffer - mainly in urine and cells
- Protein buffer - mainly inside cells
2. Henderson-Hasselbalch Equation
pH = pKa + log ([HCO₃⁻] / [CO₂])
Normal values:
- pH = 7.4
- HCO₃⁻ = 24 mEq/L
- pCO₂ = 40 mmHg
- Ratio = 20:1 (HCO₃⁻:CO₂)
Simple rule: pH follows HCO₃⁻ and goes against CO₂
- High CO₂ → acid (pH falls)
- High HCO₃⁻ → alkaline (pH rises)
3. Compensatory Responses
| Disorder | Primary Problem | Compensation |
|---|
| Metabolic acidosis | ↓ HCO₃⁻ | Lungs breathe faster → ↓ CO₂ (Kussmaul breathing) |
| Metabolic alkalosis | ↑ HCO₃⁻ | Lungs breathe slower → ↑ CO₂ |
| Respiratory acidosis | ↑ CO₂ | Kidneys retain more HCO₃⁻ |
| Respiratory alkalosis | ↓ CO₂ | Kidneys excrete more HCO₃⁻ |
Rule: The body always compensates to bring pH back toward 7.4, but NEVER fully corrects it (that would require removing the primary problem).
11. BILIRUBIN METABOLISM
1. Complete Pathway of Heme Catabolism
Step 1 - In Reticuloendothelial (RE) Cells (spleen, liver, bone marrow):
- Old RBCs are broken down
- Hemoglobin → Heme + Globin
- Heme → Biliverdin (green) - enzyme: heme oxygenase
- Biliverdin → Bilirubin (yellow/orange) - enzyme: biliverdin reductase
- At this stage, bilirubin is unconjugated (indirect) bilirubin - fat-soluble, not water-soluble
2. Transport in Blood
- Unconjugated bilirubin is fat-soluble → can't dissolve in blood alone
- It binds to albumin for transport to the liver
- It is NOT in urine at this stage (albumin-bound, too large)
3. Hepatic Conjugation
- In the liver, bilirubin is taken up from albumin
- It is conjugated (attached) to glucuronic acid by the enzyme UDP-glucuronosyltransferase (UGT)
- Now it is conjugated (direct) bilirubin - water-soluble
- Secreted into bile
4. Intestinal Excretion
- Conjugated bilirubin enters the gut via bile
- Gut bacteria convert it to urobilinogen
- Most urobilinogen → stercobilin (brown color of stool)
- Small amount of urobilinogen absorbed back into blood → some excreted in urine as urobilin (yellow color of urine)
5. Differential Diagnosis of Jaundice (Yellow skin/eyes)
| Feature | Pre-hepatic (Hemolytic) | Hepatic (Liver disease) | Post-hepatic (Obstructive) |
|---|
| Cause | Too many RBCs broken down | Liver can't process bilirubin | Bile duct blocked |
| Bilirubin type | ↑ Unconjugated | Both | ↑ Conjugated |
| Urine color | Normal (no bilirubin in urine) | Dark (urobilinogen) | Dark (conjugated bilirubin in urine) |
| Stool color | Normal/dark | Pale | Pale ("clay-colored") |
| Urine urobilinogen | ↑↑ | ↑ | Absent |
| Itching | No | Variable | Yes (bile salts in skin) |
| Examples | Malaria, sickle cell, hemolysis | Hepatitis, cirrhosis | Gallstones, pancreatic cancer |
12. UREA CYCLE
1. Detailed Enzymatic Steps
The urea cycle removes toxic ammonia (NH₃) from the body. It takes place partly in the mitochondria and partly in the cytosol.
Mitochondria steps (2 steps):
- NH₃ + CO₂ + 2ATP → Carbamoyl phosphate (enzyme: CPS-1 - carbamoyl phosphate synthetase I)
- Carbamoyl phosphate + Ornithine → Citrulline (enzyme: OTC - ornithine transcarbamoylase)
- Citrulline exits to the cytosol
Cytosol steps (3 steps):
3. Citrulline + Aspartate + ATP → Argininosuccinate (enzyme: argininosuccinate synthetase)
4. Argininosuccinate → Arginine + Fumarate (enzyme: argininosuccinase)
5. Arginine → Ornithine + UREA (enzyme: arginase)
- Ornithine goes back into mitochondria to repeat the cycle
- Urea is excreted by kidneys
Inputs: 2 NH₃ (one from mitochondria, one from aspartate) + CO₂
Output: 1 Urea (contains 2 N atoms)
Cost: 3 ATP used per urea
2. Biochemical Regulation
- N-acetylglutamate (NAG) activates CPS-I (the first enzyme)
- NAG is made when amino acids are abundant → stimulates urea cycle
- NAG synthase is activated by arginine → positive feedback (more arginine = more urea cycle activity)
- High protein diet → more amino acid breakdown → more ammonia → more urea cycle activity
3. Connection with TCA Cycle - Krebs Bicycle
- In Step 4, fumarate is released in the cytosol
- Fumarate enters the TCA cycle → becomes malate → OAA → aspartate
- Aspartate comes back to feed Step 3 of the urea cycle again
- This creates a "bicycle" (two linked cycles):
- Urea cycle provides fumarate to TCA cycle
- TCA cycle provides aspartate back to urea cycle
- They share fumarate and aspartate as the connecting metabolites
4. Hyperammonemia and Urea Cycle Defects
Hyperammonemia = too much ammonia in blood → very toxic to brain
Symptoms of high ammonia (NH₃):
- Cerebral edema (brain swelling)
- Vomiting, asterixis (liver flap - tremor)
- Confusion, coma, death
Mechanism of toxicity:
- NH₃ + α-ketoglutarate → glutamate → glutamine
- This depletes α-ketoglutarate from TCA cycle → TCA slows → less ATP → brain cells die
- Also causes cerebral edema
Genetic Urea Cycle Defects (all autosomal recessive except OTC):
| Enzyme Deficient | Disease | Key feature |
|---|
| CPS-I | CPS-I deficiency | High ammonia, normal orotic acid |
| OTC | OTC deficiency | X-linked; most common; HIGH orotic acid (carbamoyl-P spills into pyrimidine pathway) |
| Argininosuccinate synthetase | Citrullinemia type 1 | High citrulline |
| Argininosuccinase | Argininosuccinic aciduria | High argininosuccinate; brittle hair (trichorrhexis nodosa) |
| Arginase | Argininemia | High arginine; spastic diplegia |
Treatment of hyperammonemia:
- Low protein diet
- Lactulose (reduces ammonia absorption from gut)
- Sodium benzoate/phenylbutyrate (alternative pathways to excrete nitrogen)
- Liver transplant in severe genetic cases
Quick Summary Reference Card
| Topic | Key Enzyme | Key Product/Concept |
|---|
| Vitamin D | 1α-hydroxylase (kidney) | Calcitriol = active form |
| Fatty acids | CPT-1 (carnitine shuttle) | Palmitate → 106 ATP |
| Vitamin B12 | Methionine synthase | Folate trap → megaloblastic anemia |
| Cholesterol | HMG-CoA reductase (rate-limiting) | Statins block this |
| Glycolysis | PFK-1 (rate-limiting) | 2 ATP anaerobic, ~32 ATP aerobic |
| TCA cycle | Isocitrate DH, α-KG DH | 10 ATP per Acetyl-CoA |
| Enzyme inhibition | Competitive vs non-competitive | Km vs Vmax changes |
| Oxidative phosphorylation | ATP synthase (Complex V) | Chemiosmosis |
| Protein synthesis | Peptidyl transferase | Wobble at position 3 |
| Acid-base | Carbonic anhydrase | Lungs fast, kidneys slow |
| Bilirubin | UGT (conjugation) | Conjugated = water-soluble |
| Urea cycle | CPS-I (mitochondria) | OTC deficiency = X-linked |